Kosalaraksa, Pope <br/><br/>
Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants.  [electronic resource] 

 -  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  Apr 2011 
 - e249-56 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3511 
<br/><br/><label>Standard No.: </label>10.1016/j.ijid.2010.12.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--blood<br/>Antibodies, Viral--blood<br/>Diphtheria-Tetanus-acellular Pertussis Vaccines--administration & dosage<br/>Drug Therapy, Combination<br/>Haemophilus Vaccines--administration & dosage<br/>Hepatitis B Vaccines--administration & dosage<br/>Heptavalent Pneumococcal Conjugate Vaccine<br/>Humans<br/>Immunization Schedule<br/>Infant<br/>Pneumococcal Vaccines--administration & dosage<br/>Poliovirus Vaccine, Inactivated--administration & dosage<br/>Thailand<br/>Treatment Outcome<br/>Vaccination<br/>Vaccines, Combined--administration & dosage<br/>Vaccines, Conjugate--administration & dosage